Emerico Csepanyi
Family Medicine · Cerritos, CANPI 1659395036
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $140,294 of the $146,997 with a category attached, or 95.4%. AbbVie accounts for 95.6% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2023 at $45,030 and has fallen 99.8% since, to $80 in 2025. Among family medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 157 payments — averaging $936.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$140K
- Merz North America, Inc.$5K
- Pfizer$522
- Galderma Laboratories, L.p.$201
- Boehringer Ingelheim$172
- AstraZeneca$135
- plus $393 from 8 others
What the payments were for
- Speaking & faculty fees$140,29495%
- Food & beverage$6,6695%
- Education$340%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 22 | $140,478 |
| Merz North America, Inc. | 52 | $5,095 |
| Pfizer | 35 | $522 |
| Galderma Laboratories, L.p. | 9 | $201 |
| Boehringer Ingelheim | 5 | $172 |
| AstraZeneca | 9 | $135 |
| Merck | 7 | $115 |
| Sanofi-aventis U.S. LLC | 4 | $73 |
| Johnson & Johnson | 2 | $53 |
| Amarin Pharma, Inc. | 2 | $45 |
| E.r. Squibb & Sons, L.L.C. | 2 | $43 |
| Novo Nordisk | 2 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $26 |
| Lilly USA, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$146,997 in reported general payments places this provider in the 95th percentile of 10,533 family medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron Hcl | 12 | $76 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Cerritos
- Sherly SoleimanEncino$1.2M
- Pamela KushnerLos Angeles$1.2M
- Sujata NarayanStanford$1.2M
- Jeffrey UngerChino$906K
- Alexander RivkinLos Angeles$866K
- Scott HowellLos Angeles$793K
- Derrick ButlerLos Angeles$692K
- Sandra CalmanMontara$589K
- Anthony JonesOakland$377K
- Amira AyadBakersfield$360K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.